Compounds > 5-hydroxy-2-n,n-dipropylaminotetralin
Page last updated: 2024-09-05

5-hydroxy-2-n,n-dipropylaminotetralin and Central Nervous System Disease

5-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Intagliata, S; Lacivita, E; Leopoldo, M; Modica, MN; Pittalà, V; Romeo, G; Salerno, L1

Other Studies

1 other study(ies) available for 5-hydroxy-2-n,n-dipropylaminotetralin and Central Nervous System Disease

ArticleYear
Structure-Activity Relationships and Therapeutic Potentials of 5-HT
    Journal of medicinal chemistry, 2018, 10-11, Volume: 61, Issue:19

    Topics: Animals; Antidepressive Agents; Central Nervous System Diseases; Humans; Ligands; Neurodevelopmental Disorders; Receptors, Serotonin; Structure-Activity Relationship

2018